Havana, September 1 (RHC)-- The BioCubaFarma business group refuted a report by CNN about the alleged refusal by the World Health Organization (WHO) to certify Cuba's anti-Covid-19 vaccines.

The U.S. media outlet reported on Wednesday that the international entity denied authorization for the emergency use of the Cuban Abdala injectable, which means that it cannot be acquired through the Revolving Fund of the Pan American Health Organization (PAHO).

From its official Twitter profile, the state-owned conglomerate of the island's Biotechnological and Pharmaceutical Industries explained that since the first stage of development of these national drugs against Covid-19, it exchanges with the WHO-PAHO representation in the country and has kept it updated on the results.

BioCubaFarma also informed that it would soon hold talks on the pre-qualification process of Cuban vaccines to face the pandemic.

Also, on Twitter, the president of that organization, Eduardo Martínez, ratified that after the authorization of the emergency use of three Cuban anti-Covid-19 vaccines by the national regulatory entity, CECMED, it is planned to start exchanges with the WHO for their recognition.

The WHO can't have denied the granting of any license, taking into account that Cuba has not requested the proper verifications to obtain these certificates, and much less have staff from that world organization traveled to the country to check or assess the efficacy and safety of